Overview
K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
Product and company
Owkin — Biotechnology is a verified product offering linked to the Brel Digital company profile for Owkin.
Use cases
K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
Target customer
Pharmaceutical and biotechnology companies, academic medical centers, and research hospitals participating in privacy-preserving data networks.
Technologies
Primary technologies assigned from the linked company profile: Agent, Deep Learning, Federated Learning, Healthcare Analytics, Large Language Models, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://www.owkin.com/newsfeed/owkin-to-build-ai-agents-as-part-of-a-multi-year-k-pro-collaboration-with-sanofi
- Supporting source: https://www.owkin.com/about-us
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- K Pro agentic AI platform and federated learning infrastructure connecting multimodal patient data with biological reasoning models for drug discovery, trial design, and diagnostics.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.